{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:58:40Z","timestamp":1780408720653,"version":"3.54.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cld.2023.01.015","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T15:16:32Z","timestamp":1677424592000},"page":"301-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Nonalcoholic Fatty Liver Disease in Latin America and Australia"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-2064","authenticated-orcid":false,"given":"Marlen Ivon","family":"Castellanos-Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-8499","authenticated-orcid":false,"given":"Shreya C.","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0499-4191","authenticated-orcid":false,"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8561-396X","authenticated-orcid":false,"given":"Juan Pablo","family":"Arab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-5476","authenticated-orcid":false,"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-8048","authenticated-orcid":false,"given":"Nahum","family":"M\u00e9ndez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.cld.2023.01.015_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet"},{"issue":"10113","key":"10.1016\/j.cld.2023.01.015_bib2","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults","volume":"390","author":"Collaboration","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Collaborators","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/apt.17158","article-title":"Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world","volume":"56","author":"Henry","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"10290","key":"10.1016\/j.cld.2023.01.015_bib5","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","article-title":"Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease","volume":"19","author":"Arab","year":"2020","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib7","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2023.01.015_bib8","doi-asserted-by":"crossref","first-page":"100142","DOI":"10.1016\/j.jhepr.2020.100142","article-title":"Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study","volume":"2","author":"O'Hara","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2023.01.015_bib10","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib11","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1038\/s41598-021-84577-z","article-title":"The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017","volume":"11","author":"Zhai","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.cld.2023.01.015_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11938-022-00382-1","article-title":"Liver diseases in Latin America: current status, unmet needs, and opportunities for improvement","volume":"20","author":"Diaz","year":"2022","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.cld.2023.01.015_bib14","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3748\/wjg.v20.i17.4987","article-title":"NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis","volume":"20","author":"Fleischman","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2023.01.015_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cgh.2014.08.037","article-title":"Prevalence of suspected nonalcoholic fatty liver disease in Hispanic\/Latino individuals differs by heritage","volume":"13","author":"Kallwitz","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.01.015_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40985-016-0043-2","article-title":"Hispanic health in the USA: a scoping review of the literature","volume":"37","author":"Velasco-Mondragon","year":"2016","journal-title":"Public Health Rev"},{"key":"10.1016\/j.cld.2023.01.015_bib17","author":"Kittleson"},{"issue":"4","key":"10.1016\/j.cld.2023.01.015_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/674945","article-title":"Islands of knowledge: science and agriculture in the history of Latin America and the Caribbean","volume":"104","author":"Fernandez Prieto","year":"2013","journal-title":"Isis"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/s0104-59702021000100012","article-title":"Framing the Latin American nutrition transition in a historical perspective, 1850 to the present","volume":"28","author":"Ablard","year":"2021","journal-title":"Hist Cienc Saude Manguinhos"},{"key":"10.1016\/j.cld.2023.01.015_bib20","author":"Latin"},{"issue":"5","key":"10.1016\/j.cld.2023.01.015_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3917\/popu.605.0623","article-title":"La d\u00e9mographie de l'Am\u00e9rique latine et de la Cara\u00efbe depuis 1950","volume":"61","author":"Guzm\u00e1n","year":"2006","journal-title":"Population"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12939-021-01426-1","article-title":"Understanding inequities in health and health systems in Latin America and the Caribbean: a thematic series","volume":"20","author":"Ruano","year":"2021","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.cld.2023.01.015_bib23","doi-asserted-by":"crossref","first-page":"100359","DOI":"10.1016\/j.aohep.2021.100359","article-title":"NAFLD: challenges and opportunities to address the public health problem in Latin America","volume":"24","author":"Arab","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2023.01.015_bib24","author":"Center"},{"issue":"12","key":"10.1016\/j.cld.2023.01.015_bib25","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cld.759","article-title":"Nonalcoholic fatty liver disease risk factors in Latin American populations: current scenario and perspectives","volume":"13","author":"Pinto Marques Souza de Oliveira","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2023.01.015_bib27","first-page":"453","article-title":"Prevalence of nonalcoholic fatty liver and metabolic syndrome in asymptomatic population","volume":"71","author":"Lizardi-Cervera","year":"2006","journal-title":"Rev Gastroenterol M\u00e9xico"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib28","doi-asserted-by":"crossref","first-page":"e0208926","DOI":"10.1371\/journal.pone.0208926","article-title":"High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population","volume":"14","author":"Sepulveda-Villegas","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S1516-31802007000600006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults","volume":"125","author":"Karnikowski","year":"2007","journal-title":"Sao Paulo Med J"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1665-2681(19)30879-8","article-title":"The prevalence of nonalcoholic fatty liver disease in the Americas","volume":"13","author":"Lopez-Velazquez","year":"2014","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01823.x","article-title":"Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics","volume":"29","author":"Riquelme","year":"2009","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ypmed.2010.11.021","article-title":"Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population","volume":"52","author":"Perez","year":"2011","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib33","first-page":"64","article-title":"Non-alcoholic fatty liver disease in Cuba","volume":"23","author":"Castellanos-Fernandez","year":"2021","journal-title":"MEDICC Rev"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjcard.2014.09.044","article-title":"Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk","volume":"115","author":"Oni","year":"2015","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.cld.2023.01.015_bib35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1590\/S0102-86502013001100008","article-title":"The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors","volume":"28","author":"Feijo","year":"2013","journal-title":"Acta Cir Bras"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib36","doi-asserted-by":"crossref","first-page":"100706","DOI":"10.1016\/j.aohep.2022.100706","article-title":"Non-alcoholic fatty liver disease prevalence in Latin America: a systematic review and meta-analysis","volume":"27","author":"Rojas","year":"2022","journal-title":"Ann Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.01.015_bib37","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/obr.12694","article-title":"Obesity and the food system transformation in Latin America","volume":"19","author":"Popkin","year":"2018","journal-title":"Obes Rev"},{"key":"10.1016\/j.cld.2023.01.015_bib38","author":"Australian Government AIoHaWA"},{"issue":"10026","key":"10.1016\/j.cld.2023.01.015_bib39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants","volume":"387","author":"Collaboration","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cld.2023.01.015_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCG.0000000000000622","article-title":"Elevated liver enzymes and mortality in older individuals: a prospective cohort study","volume":"51","author":"Mahady","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2023.01.015_bib41","author":"Statistics ABo"},{"issue":"9","key":"10.1016\/j.cld.2023.01.015_bib42","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/jgh.15009","article-title":"Nonalcoholic fatty liver disease burden: Australia, 2019-2030","volume":"35","author":"Adams","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib43","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cgh.2016.09.149","article-title":"Acculturation and nonalcoholic fatty liver disease risk among hispanics of Mexican origin: findings from the national health and nutrition examination survey","volume":"15","author":"Balakrishnan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cgh.2015.05.001","article-title":"Nonalcoholic fatty liver disease in latinos","volume":"14","author":"Saab","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib47","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s42003-021-02431-4","article-title":"Impact of Amerind ancestry and FADS genetic variation on omega-3 deficiency and cardiometabolic traits in Hispanic populations","volume":"4","author":"Yang","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.cld.2023.01.015_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/DMSO.S182331","article-title":"Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease","volume":"12","author":"Szanto","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"10.1016\/j.cld.2023.01.015_bib49","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4254\/wjh.v13.i7.763","article-title":"Racial differences in prevalence and severity of non-alcoholic fatty liver disease","volume":"13","author":"Bonacini","year":"2021","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cgh.2018.08.002","article-title":"Sex-based differences in the association between nonalcoholic fatty liver disease and mortality","volume":"17","author":"Ye","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2023.01.015_bib51","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2023.01.015_bib52","doi-asserted-by":"crossref","first-page":"e1644","DOI":"10.1016\/S2214-109X(19)30421-8","article-title":"The shift of obesity burden by socioeconomic status between 1998 and 2017 in Latin America and the Caribbean: a cross-sectional series study","volume":"7","author":"Jiwani","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cld.2023.01.015_bib53","unstructured":"(FLASO) LAFoOS. II Consenso Latino-Americano de Obesidad. 2017. In: (FLASO) LAFoOS, editor. 2017."},{"key":"10.1016\/j.cld.2023.01.015_bib54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fpubh.2020.00330","article-title":"Funding of hispanic\/latino health-related research by the national institutes of health: an analysis of the portfolio of research Program grants on six health topic areas","volume":"8","author":"Aviles-Santa","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.cld.2023.01.015_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.annepidem.2021.07.005","article-title":"Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA)","volume":"63","author":"Rodriguez","year":"2021","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.cld.2023.01.015_bib56","first-page":"104","article-title":"Relationship between health behaviors and obesity in a sample of hawai'i's 4 most populous ethnicities","volume":"79","author":"Yoshida","year":"2020","journal-title":"Hawaii J Health Soc Welf"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib57","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pcd.2020.10.001","article-title":"Review: type 2 diabetes in Latin America and the Caribbean: regional and country comparison on prevalence, trends, costs and expanded prevention","volume":"15","author":"Gallardo-Rincon","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.cld.2023.01.015_bib58","first-page":"112","article-title":"Diabetes in Latin America: prevalence, complications, and socio-economic impact","volume":"6","author":"Sinisterra-Loaiza","year":"2019","journal-title":"International Journal of Diabetes and Clinical Research"},{"issue":"10","key":"10.1016\/j.cld.2023.01.015_bib59","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1016\/S2214-109X(18)30357-7","article-title":"Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants","volume":"6","author":"Guthold","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cld.2023.01.015_bib60","author":"Statistics ABo"},{"key":"10.1016\/j.cld.2023.01.015_bib61","author":"Statistics ABo"},{"key":"10.1016\/j.cld.2023.01.015_bib62","author":"Australian Government AIoHaWA"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib63","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Trepo","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib64","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"issue":"Suppl 7","key":"10.1016\/j.cld.2023.01.015_bib65","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/cncr.31122","article-title":"High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease","volume":"124","author":"Tepper","year":"2018","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.cld.2023.01.015_bib66","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.cgh.2019.02.007","article-title":"American ancestry is a risk factor for suspected nonalcoholic fatty liver disease in hispanic\/latino adults","volume":"17","author":"Kallwitz","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib67","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2020.01.029","article-title":"A\u00a0common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank","volume":"72","author":"Walker","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.01.015_bib68","first-page":"1285A","article-title":"High prevalence of PNPLA3 rs738409 (I148M) polymorphism in Chilean latino population and its association to non-alcoholic fatty liver disease risk and histological disease severity","volume":"62","author":"Arrese","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.01.015_bib69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12863-015-0255-3","article-title":"Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations","volume":"16","author":"Pontoriero","year":"2015","journal-title":"BMC Genet"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib70","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2023.01.015_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4254\/wjh.v9.i7.391","article-title":"Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites","volume":"9","author":"Venepalli","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cld.2023.01.015_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40364-017-0096-5","article-title":"Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review","volume":"5","author":"Ha","year":"2017","journal-title":"Biomark Res"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib74","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/liv.13502","article-title":"Hepatocellular carcinoma in South America: evaluation of risk factors, demographics and therapy","volume":"38","author":"Debes","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1665-2681(19)31681-3","article-title":"Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study","volume":"9","author":"Fassio","year":"2010","journal-title":"Ann Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.01.015_bib77","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejim.2013.09.003","article-title":"Cardiovascular mortality in Hispanics compared to non-Hispanic whites: a systematic review and meta-analysis of the Hispanic paradox","volume":"24","author":"Cortes-Bergoderi","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.cld.2023.01.015_bib78","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2105\/AJPH.2012.301103","article-title":"Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature","volume":"103","author":"Ruiz","year":"2013","journal-title":"Am J Public Health"},{"issue":"8","key":"10.1016\/j.cld.2023.01.015_bib79","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.cgh.2018.10.045","article-title":"Disparate trends in mortality of etiology-specific chronic liver diseases among hispanic subpopulations","volume":"17","author":"Kim","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2023.01.015_bib80","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.cgh.2018.12.041","article-title":"Hepatocellular carcinoma among hispanics: an understudied public health priority","volume":"17","author":"Callahan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib81","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cgh.2020.04.083","article-title":"Type 2 diabetes and metformin use associate with outcomes of patients with nonalcoholic steatohepatitis-related, child-pugh A cirrhosis","volume":"19","author":"Vilar-Gomez","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib82","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/hep.31576","article-title":"ABIDE: an accurate predictive model of liver decompensation in patients with nonalcoholic fatty liver-related cirrhosis","volume":"73","author":"Calzadilla-Bertot","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2023.01.015_bib83","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2023.01.015_bib84","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","article-title":"The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas","volume":"7","author":"Diaz","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2023.01.015_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.16720","article-title":"A\u00a0sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach","volume":"55","author":"Lazarus","year":"2022","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:13Z","timestamp":1761069553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1089326123000156"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.01.015","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic Fatty Liver Disease in Latin America and Australia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}